Effects of a Walking Program on Functional Status of Post-Surgical Lumbar

Status Enrolling by invitation

Clinical Trial Summary

Overall Objective: To evaluate the efficacy of an interventional walking program on the quality of life and functional status of patients with Lumbar Spinal Stenosis, post-surgery, using subjective (VAS, ODI, RMDQ, SF-36), and objective measures (triaxial accelerometry, step count, weight).

Design and Methods: Two groups of subjects will be examined; patients diagnosed with lumbar spinal stenosis (LSS) that progress to surgical management, with one group of subjects staring on the walking program at 2 months postop, and the other group starting on the walking program at 3 months postop.

Subjects who agree to participate will be assessed (assessments listed below) after the diagnosis preoperatively and 2 months postoperatively. One half of the group will start the walking program at the 2 months postop visit and be assessed again at the end of the walking program, the other half will be assessed again at 3 months postop and start the walking program at that time and be assessed again at 4 months postop. All subjects will be contacted by phone during their walking program to allow for questions from the subjects and to offer support and encouragement. Subjects will be given instructions and a daily diary to track steps taken each day (appendix A).

Subjects will be recruited from the referrals to the practices of the Orthopedic and Neurosurgery Spine Surgeons at the Health Sciences Centre in Winnipeg. This encompasses the majority of new and currently managed cases in the Manitoba and Northwestern Ontario.

Subjects will be between the ages of 18 and 90. Male and female subjects will be recruited into the study. All LSS patients will demonstrate intractable neurogenic claudication and radiographically confirmed lumbar spinal stenosis. Exclusion criteria will be any previous lumbar spine surgery, the existence of significant co-morbidity (e.g. neurologic or cardiac condition, disease, etc.) of any form, and any other physical limitations (musculoskeletal injury) preventing the subject from participating in regular activity and the walking program. Subjects participating will be required to speak English.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00958490
Study type	Interventional
Source	University of Manitoba
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	June 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04795284` - Biomechanical Parameters of Gait in Patients With Symptomatic Lumbar Spinal Stenosis and Healthy Elderly.
Recruiting	`NCT04066296` - Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine	Phase 2
Active, not recruiting	`NCT05114135` - TLIF Osteo3 ZP Putty Study (Also Known as the TOP Fusion Study)	N/A
Recruiting	`NCT06075862` - Balance Amongst Patients With Lumbar Spinal Stenosis
Recruiting	`NCT06057428` - Activity Levels Amongst Patients With Lumbar Spinal Stenosis
Recruiting	`NCT05527145` - Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial	N/A
Recruiting	`NCT01902979` - The Spinal Stenosis Pedometer and Nutrition e-Health Lifestyle Intervention (SSPANLI) Trial	N/A
Completed	`NCT00749073` - The Vertos MILD™ Preliminary Patient Evaluation Study	N/A
Completed	`NCT00527527` - Chiropractic Dosage for Lumbar Stenosis	Phase 2
Completed	`NCT00405691` - Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis	Phase 3
Completed	`NCT03194607` - Quantitative Evaluation of Motor Function Before and After Surgery for Degenerative Lumbar Spinal Stenosis
Recruiting	`NCT06034405` - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Completed	`NCT06079580` - Patients With Lumbar Spinal Stenosis With Balance Disorder
Recruiting	`NCT05523388` - Role of Spinal Load in the Pathophysiology of Lumbar Spinal Stenosis
Completed	`NCT04587401` - The Effects of Anesthesia on Cerebral Perfusion in Patients With High Blood Pressure	N/A
Completed	`NCT04563793` - Postmarket Outcomes Study for Evaluation of the Superion™ Spacer
Suspended	`NCT03381677` - Pedicle Osteotomy for Stenosis Trial	N/A
Completed	`NCT02258672` - Preoperative Rehabilitation for Patients Undergoing Surgery for Lumbar Spinal Stenosis	N/A
Completed	`NCT02260401` - Long Term Outcomes of Lumbar Epidural Steroid Injections for Spinal Stenosis	N/A
Completed	`NCT01994512` - Swedish Spinal Stenosis Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of a Walking Program on Functional Status of Post-Surgical Lumbar Spinal Stenosis Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms